Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Pornpan Koomanachai, Jared L Crandon & David P Nicolau. (2009) Newer developments in the treatment of Gram-positive infections. Expert Opinion on Pharmacotherapy 10:17, pages 2829-2843.
Read now
Read now
A. Gonzalez-Ruiz & J. Richardson. (2008) Are Glycopeptides Still Appropriate and Convenient for Empiric Use?. Journal of Chemotherapy 20:5, pages 531-541.
Read now
Read now
Paul B Cornia, Heather L Davidson & Benjamin A Lipsky. (2008) The evaluation and treatment of complicated skin and skin structure infections. Expert Opinion on Pharmacotherapy 9:5, pages 717-730.
Read now
Read now
Articles from other publishers (17)
Kimberly G. Blumenthal, Robert A. Parker, Erica S. Shenoy & Rochelle P. Walensky. (2015)
Improving Clinical Outcomes in Patients With Methicillin-Sensitive
Staphylococcus aureus
Bacteremia and Reported Penicillin Allergy
. Clinical Infectious Diseases 61:5, pages 741-749.
Crossref
Crossref
Alberto Cogo, Armando Gonzalez-Ruiz, Rashidkhan Pathan & Kamal Hamed. (2015) Real-World Treatment of Complicated Skin and Soft Tissue Infections with Daptomycin: Results from a Large European Registry (EU-CORE). Infectious Diseases and Therapy 4:3, pages 273-282.
Crossref
Crossref
Nancy Sandoval, Santiago Grau, Luisa Sorlí, Milagro Montero, Erika Esteve & Juan Pablo Horcajada. (2015) Clinical experience with the use of daptomycin in a tertiary care teaching hospital in Barcelona, Spain. Future Microbiology 10:7, pages 1145-1154.
Crossref
Crossref
Alexander Konychev, Markus Heep, Rose K. C. Moritz, Alexander Kreuter, Alexander Shulutko, Gerhard Fierlbeck, Kamel Bouylout, Rashidkhan Pathan, Uwe Trostmann & Ricardo L. Chaves. (2013) Safety and Efficacy of Daptomycin as First-Line Treatment for Complicated Skin and Soft Tissue Infections in Elderly Patients: An Open-Label, Multicentre, Randomized Phase IIIb Trial. Drugs & Aging 30:10, pages 829-836.
Crossref
Crossref
Gregory J. Moran, Fredrick M. Abrahamian, Frank LoVecchio & David A. Talan. (2013) Acute Bacterial Skin Infections: Developments Since the 2005 Infectious Diseases Society of America (IDSA) Guidelines. The Journal of Emergency Medicine 44:6, pages e397-e412.
Crossref
Crossref
Mark Bounthavong, Amir Zargarzadeh, Donald I. Hsu & David J. Vanness. (2011) Cost-Effectiveness Analysis of Linezolid, Daptomycin, and Vancomycin in Methicillin-Resistant Staphylococcus aureus: Complicated Skin and Skin Structure Infection Using Bayesian Methods for Evidence Synthesis. Value in Health 14:5, pages 631-639.
Crossref
Crossref
E. Bouza. (2009) New therapeutic choices for infections caused by methicillin-resistant Staphylococcus aureus. Clinical Microbiology and Infection 15, pages 44-52.
Crossref
Crossref
Elizabeth D. Hermsen, Sara S. Shull, Isaac F. Mitropoulos, Susan E. Puumala & Mark E. Rupp. (2009) Prospective Evaluation of Clinical and Economic Outcomes Associated With Treatment of Serious Infections Due to Gram-Positive Cocci. Infectious Diseases in Clinical Practice 17:1, pages 17-21.
Crossref
Crossref
Kurt A. WargoEdward H. EilandIIIIII & Lea S. Eiland. (2008)
Management and Treatment Considerations for Infections Caused by Methicillin-Resistant
Staphylococcus aureus
. Journal of Pharmacy Practice 21:5, pages 324-336.
Crossref
Crossref
Lena M. Napolitano. (2008)
Early Appropriate Parenteral Antimicrobial Treatment of Complicated Skin and Soft Tissue Infections Caused by Methicillin-Resistant
Staphylococcus aureus
. Surgical Infections 9:s1, pages s17-s27.
Crossref
Crossref
Elena Loza, María Isabel Morosini, Álvaro Pascual, Fe Tubau, Juan Alcalá, Josefina Liñares, José Ramón Hernández-Bello, Fernando Baquero, Evelio Perea, Rogelio Martín, Ronald N. Jones & Rafael Cantón. (2008) Actividad comparativa de daptomicina frente a microorganismos grampositivos: programa SENTRY España (2002-2006). Enfermedades Infecciosas y Microbiología Clínica 26:8, pages 489-494.
Crossref
Crossref
D.Y. Aksoy & S. Unal. (2008) New antimicrobial agents for the treatment of Gram-positive bacterial infections. Clinical Microbiology and Infection 14:5, pages 411-420.
Crossref
Crossref
S. Roveta, A. Marchese & G.C. Schito. (2008) Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp.. International Journal of Antimicrobial Agents 31:4, pages 321-328.
Crossref
Crossref
Jason G Newland & Gregory L Kearns. (2008) Treatment Strategies for Methicillin-Resistant Staphylococcus aureus Infections in Pediatrics. Pediatric Drugs 10:6, pages 367-378.
Crossref
Crossref
Gary J. Noel, Richard S. Strauss, Karen Amsler, Markus Heep, Rienk Pypstra & Joseph S. Solomkin. (2008) Results of a Double-Blind, Randomized Trial of Ceftobiprole Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria. Antimicrobial Agents and Chemotherapy 52:1, pages 37-44.
Crossref
Crossref
Samir S. Awad, Saleem I. Elhabash, Liz Lee, Buckmister Farrow & David H. Berger. (2007) Increasing incidence of methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: reconsideration of empiric antimicrobial therapy. The American Journal of Surgery 194:5, pages 606-610.
Crossref
Crossref
David A. Enoch, Jeanine M. Bygott, Marie-Louise Daly & J. Andreas Karas. (2007) Daptomycin. Journal of Infection 55:3, pages 205-213.
Crossref
Crossref